Covidien recently announced that the FDA has cleared its next generation LigaSure surgical tool.
The company announced the 510(k) clearance for the LigaSure Maryland jaw open/laparoscopic sealer/divider on Wednesday, saying that it has also completed all European requirements to CE Mark the product. The plan is to launch the new vessel sealer and divider in the United States and Europe during the present quarter. Electrosurgical Unit Monopolar Bipolar
The design of the new LigaSure Maryland jaw device allows surgeons to grasp, seal and cut tissue with minimal steps and reduced instrument exchanges. It takes LigaSure's energy-based vessel sealing technology and combines it with the functionality of three common surgical tools: a Maryland dissector, which is a blunt surgical tool with a curved jaw used to separate, grasp and manipulate tissue; an atraumatic tissue grasper; and cold surgical scissors.
Chris Barry, president of Advanced Surgical at Covidien, claimed in a news release that the device "further demonstrates Covidien's commitment to expand energy device options with solutions targeted at specific procedures and surgeon use needs."In other new Covidien news, the company says it has officially opened its first training and education center in India.
Neuronetics Nabs FDA Clearance for NeuroStar Treatment in Adolescents
Scivita Medical Expands Endoscope Collaboration with Boston Scientific
Masimo Faces Second Proxy Fight in Wake of a Major Announcement
Get in Front of Twin Cities Medical Innovators at MD&M Minneapolis
Megadyne Electrosurgical Generator Copyright © 2024 All rights reserved. Informa Markets, a trading division of Informa PLC.